Physicians used point of care rapid immunoassay tests to provide influenza results during H1N1 pandemic
In Apr. 2009, physicians used point of care rapid immunoassay tests to provide influenza results within 15 minutes…
An increased risk of narcolepsy was found following vaccination with Pandemrix
In 2009, an increased risk of narcolepsy (a chronic sleep disorder) was found following vaccination with Pandemrix, a…
Biotechnology | FDA | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had licensed Pentacel, Diphtheria…
CDC updated its recommendations for administering combination MMRV vaccine
On Mar. 14, 2008, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendations for administering…
ACIP voted to expand influenza recommendation to include vaccination for children ages 6 months-18 years
On Feb. 27, 2008, the Immunization Practices Advisory Committee (Immunization Practices Advisory Committee (ACIP) voted to expand influenza…
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
CDC | Diagnostics | Influenza | Therapeutics
The Influenza Reagent Resource was established by the CDC
In 2008, the Influenza Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC)…
FDA approved use of FluMist nasal-spray influenza vaccine in children age 2-5 years
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…
Biotechnology | COVID-19 | Diagnostics | Disease | Influenza | Plague | Therapeutics | Vaccine
Fort Knox prepared for pandemic outbreak scenarios
On Jun. 7, 2007, years before the COVID-19 pandemic swept across the globe, a group of about 100…
CDC published Interim Pre-pandemic Planning Guidance Strategy for Pandemic Influenza Mitigation in the U.S.
On Feb. 1, 2007, the Centers for Disease Control and Prevention (CDC) released its long-awaited disease containment strategy…
FDA licensed the refrigerator formulation of FluMist
On Jan. 9, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
Biotechnology | CDC | Influenza | Therapeutics | Vaccine
Human infection with a novel influenza virus was added to the nationally notifiable disease list
On Jan. 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists approved an interim…
Biotechnology | CDC | Diagnostics | Influenza | Vaccine
CDC stopped recommending adamantanes during 2005 season after high levels of influenza A (H3N2) virus resistance
On Jan. 17, 2006, the Centers for Disease Control and Prevention (CDC) announced that it had stopped recommending…
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
HHS Pandemic Influenza Plan was published
In 2005 and 2006, the White House Homeland Security Council outlined the National Strategy for Pandemic Influenza to…
A significant shortage of influenza vaccine occurred in the U.S.
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
ACIP voted to recommend influenza vaccination for children aged 6 to 23 months
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
The first nasally administered influenza vaccine (FluMist by MedImmune) was licensed
On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…
The ACIP encouraged that children 6 to 23 months of age be vaccinated annually against influenza
On Jan. 1, 2003, the Advisory Committee on Immunization Practices (ACIP) encouraged that children 6 to 23 months…
Roche received FDA approval of TAMIFLU, first pill to treat most common strains of influenza (A&B)
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU (oseltamivir phosphate) had been approved…
Neuraminidase inhibitors Tamiflu and Relenza were licensed to treat influenza infection
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU™ (oseltamivir phosphate) has been approved…
A pandemic planning framework was published by the World Health Organization
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
Biotechnology | Diagnostics | Influenza | Vaccine | WHO
FluNet, a web-based flu surveillance tool, was launched by the WHO
In 1997, FluNet, a global web-based tool for influenza virological surveillance was launched. It is a critical tool…
Rimantadine was approved by the FDA to treat influenza A
In 1994, Rimantadine, derived from amantadine, was approved by the Food and Drug Administration (FDA) to treat influenza…
The costs of influenza vaccine and its administration became a covered benefit under Medicare Part B
On May 1, 1993, the costs of influenza vaccine and its administration became a covered benefit under Medicare…
A combined Haemophilus influenzae type b vaccine and whole cell DTP vaccine was licensed
On Mar. 1, 1993, the combined Haemophilus influenzae type b vaccine and whole cell DTP vaccine (Tetramune by…
Biotechnology | FDA | Influenza | Vaccine
The FDA approved PRP-OMP for routine administration to infants beginning at 2 months of age
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
The FDA approved the use of HbOC for routine administration to infants beginning at 2 months of age
On Oct. 4, 1990, the FDA approved the use of Haemophilus b Conjugate Vaccine (Diphtheria CRM 197 Protein…
Biotechnology | CDC | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO
The CDC established a World Health Organization (WHO) collaborating center for disaster preparedness
In 1989, the U.S. Centers for Disease Control and Prevention (CDC) established a World Health Organization (WHO) collaborating…